Obesity & Diabetes Flashcards

1
Q

what is a complex phenotypeq

A

the consequence of complex interactions of large number of genetic + non-genetic determining factors
- obesity is a complex phenotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 types of obesity

A

1) monogenic obesity = single gene mutation usually in leptin-metalocortin pathway
- serious but rare
2) syndromic obesity = severe obesity, assoc w other phenotypes (neurodevelopmental abnormalities) or other organ/system malformations
3) polygenic obesity = cumulative contribution of large number of mutations, effect is amplifed by weight gaining environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

example of monogenic cause of obesity

A
  • nonsense/ recessive mutation to leptin ob gene –> stop codon –> non functional leptin = insatiable appetite = mice keep eating
    OB PHENOTYPE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what does leptin regulate ?

A
  • leptin is secreted by adipocytes into blood –> moves through blood brain barrier –> binds specific receptor on hypothalamus
  • ->regulates NAMRE
    1) neuropeptide Y expression
    2) appetite
    3) metabolic rate
    4) reporductive function
    5) energy expenditure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

congenital leptin deficinecy

A
  1. homozygous for frameshift mutation on ob gene
    - causes hyperphagia
  2. constant eating, insatiable appetite)
  3. advanced skeletal maturation
  4. impaired T cell mediated immunity
  5. hypogonadotropic hypogonadism (problem w pit gland/ hypo= produce no sex hormones)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MC4R deficiency

A
  • monogenic obesity= most common of all monogenic obesity (1 in 2000)
  • MC4R= critical relay centre in hypothalamus = send projections to other strcutres in brain (strucutres involved in reward + satiety)

1) codominant inheritance
2) results in early onset of obesity
3) hyperphagia since 1 st yr
4) increased fat mass + lean mass
5) increase bone mineral density
6) increased linear growth
7) disporportionate hyperinsulinaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

GWAS studies of obesity

A

1) 75 obesity susceptibility loci
2) many located in non coding areas
3) large prop of loci r undiscovered (identified loci explain only 2-4% of obesity heritability- large prop of loci remain undiscovered)
4) obesity linked genes highly expressed in brain (regions involving regulating appetite + food intake)
5) neuronal influence on body weight
6) BMI = GWAS found variants related to body fat distribution (waist circumference/ waist:hip ratio)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

FTO

A
  • first gene identified by GWAS for obesity susceptibility
  • locus has largest effect on BMI + obesity risk = LARGE EFFECT SIZE
  • FTO = RNA demethylase (links function to epigenetics)

FTO mediates effect on BMI –>
SNP in FTO gene =assoc. w NON ADIPOSITY TRAITS = cardiometabolic traits, T2D, osteoarthritis

  • RISK ALLELE A= variant rs1558902 of FTO gene = interacts w dietary proteins (proteins assoc w changes in body comp + abdominal fat distribution)
  • -> HIGH protein diet =
    1) weight loss
    2) improvement of body composition + fat distribution compared to NON carriers of allele A = LARGE EFFECT SIZE

NUTRTION + LIFESTYLE ADVICE:

1) useful to eat foods that promote satiety = HIGH PROTEIN DIET
2) importance of execise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

severe early onset obesity

A
  • treated with leptin administration

- those that are resistant to leptin administration = have rare mutation in leptin receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

order of hyperphagia (increased eating behaviour)

A
  1. leptin deficiency (ob mutation)
  2. MC4R mutation complete
  3. MC4R mutation partial
  4. controls (healthy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

explain T2D cause & background

A

1) result of excess body weight + physical inactivity + modern day lifestyle/diet
2) caused by:
1. insulin resistance
2. beta cell dysfunction
3) results in microvascular + macrovascular complications
- significant impact on healthcare costs
3) symptoms are similar to T1D but are less marked
4) disease may be diagnosed years after onset, once complications have already begun
5) increasingly seen in chidlren as well (90% of diabetes in the world)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

insulin production pathway

A

translation of insulin –> pre-cursor signal peptide removed –> cleaved into 3 peptides: A, B C –> A + B peptides joined by disulphide bonds –> forms insulin + C peptide –> Insulin binds insulin receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T1D rough explain

A
  • autoimmune disease = onset is not affected by lifestyle
  • cause not known
  • not preventable
  • result of no insulin production (beta cell destroyed)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pathology of T2D?

A

serious & progressive characterised by

1) insulin resistance
2) beta cell dysfunction

causes microvascular + macrovascular compliations

1) insulin receptors on cells down-regulated
2) liver, skeletal + muscle cells progressively less sensitive to insulin

3) insulin overproduction weakens beta cells
(prod so much bc receptor isnt responding to it- causes beta cells to weaken)

4) reduced ability for beta cells to secrete insulin
5) impaired ability for beta cells to compensate for insulin resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

MODY features

A
  • monogenic/ Mendelian form of diabetes mellitus
  • mody genotype determines phenotype = determines TREATMENT
  • Mendellian pattern of inheritance
  • early age onset + pancreatic beta cell dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe the genes involved in mendelian/ monogenic forms of diabetes

A

1) mendelian patterns of inheritance
2) single gene mutation= some genes are components of insulin secretory pathways (ABCC8, GCK, INS) + transcription factors in pancreas + liver development (HNF1A, HNF4A)

3) all MODY genes are expressed in the pancreas
- have a role in :
1. metabolism of glucose
2. regulation of insulin/ other genes involved in glc transport
3. development of fetal pancreas

17
Q

pathway of glucose stimulated insulin secretion

A

important proteins:

  • GCK
  • GLUT1/2/3 (SLC2A1/ 2/3)
  • insulin (INS)
  • ATP sensitive K+ channel (made of 4 SUR1 + 4 Kir6.2 subunits)
  • voltage gated Ca2+ channels (CaV - represent both p/q type + L type channels)

glucose enters cells through GLUT transport 1/2/3 –> GCK phosphorylates glucose to G-6-Phosphate

changes in ATP;ADP ratio INactivates ATP sensitive K+ channel –> closes K+ channel causes membrane depolarisation –> opens voltge gated Ca2+ channel –> influx Ca2+ channel stimulates exocytosis of insulin granules

18
Q

gives a specific example of MODY/ monogenic form of diabetes
- HNF4A example

A
  • form of MODY

mutation in HNF4A = assoc with :

1) increase in birth weight
- macrosomia (bby born much larger than avg)
3) hypoglycemia @ birth
4) adolescent onset of diabetes
5) progressive beta cell dysfunction

treatment: long term treatment of SULPONYLUREAS (more effective than insulin treatment)

19
Q

what is common consequence of mutations in monogenic forms of diabetes

A

HYPERGLYCEMIA

20
Q

what are patients with HNF1A or HNF4A treated with + why?

A

1) Long term low dose SULFONYLUREAS (stimulate insulin produciton + increase insulin effectiveness)

2) good glycemic control
3) low carb diet might be helpful + EXERCISE

WHY?
- progressive deterioration in panreas beta cell function

21
Q

why is exercise helpful with diabetes

A

exercise INCREASES insulin sensitivity

22
Q

what are pateints with GCK MODY treated with?

A
  • mutation to Glucokinase

- NO TREATMENT

23
Q

what are patients with gestational diabetes treated with?

A
  • treatment is required
  • if HbA1C > 6.5% OR fasting BGL >126mg/dL
    use Metformin ( reduce fasting BGL )
  • but if that still wont control BGL = means that BOTh insulin secretion + hepatic glucose production are ABNORMAL
  • must use exogenous insulin